Sangamo Therapeutics, Inc (SGMOQ) stock
SGMOQOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q1 năm tài chính 2026, quý kết thúc ngày Mar 31, 2026Last filing: 10-Q on May 14, 2026Score 4/30
$0.10−0.01 (-8.17%)
Close on Oct 19, 2026Market cap $39.43MP/E –Yield –
Sangamo Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Sangamo Therapeutics's price to book ratio was 21.4× on Jan 30, 2026, against 6.1× a year earlier. Over the last 5 years it ranged from 0.4× to 23.4×, with a median of 2.5×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jan 30, 2026 | 21.4× | +4.8 |
| 2025 | Dec 31, 2025 | 16.7× | +11.6 |
| 2024 | Dec 31, 2024 | 5.1× | +4.4 |
| 2023 | Dec 29, 2023 | 0.7× | −0.8 |
| 2022 | Dec 30, 2022 | 1.5× | −1.1 |
| 2021 | Dec 31, 2021 | 2.7× | −1.2 |
| 2020 | Dec 31, 2020 | 3.8× | +1.7 |
| 2019 | Dec 31, 2019 | 2.2× | −0.9 |
| 2018 | Dec 31, 2018 | 3.1× | −4.3 |
| 2017 | Dec 29, 2017 | 7.4× | +5.9 |
| 2016 | Dec 30, 2016 | 1.5× | −1.6 |
| 2015 | Dec 31, 2015 | 3.1× | −1.8 |
| 2014 | Dec 31, 2014 | 4.9× | −1.8 |
| 2013 | Dec 31, 2013 | 6.8× | +2.0 |
| 2012 | Dec 31, 2012 | 4.8× | +3.0 |
| 2011 | Dec 30, 2011 | 1.8× | – |
See a number that looks wrong?